Roquefort Therapeutics PLC (ROQ)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1.20p

Buy

1.40p

arrow-up0.00p (+0.00%)

Prices updated at 19 Dec 2025, 16:21 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Stephen Paul West
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
1
Head office
85 Great Portland Street
London
United Kingdom
W1W 7LT
mobile
+44 2039188633
letter
-

Key personnel

Salary
Ms. Jean Duvall
Non-Executive Director
-
Dr. Simon Sinclair
Non-Executive Director
-
Dr. Darrin Matthew Disley
Executive Director, Managing Director(intm)
-
Mr. Stephen Paul West
Executive Director, Chairman
-

Top 5 shareholders

No. of shares
No data

Director dealings

Action
21 Nov 2025Purchase
04 Jul 2025Purchase
27 Jun 2025Purchase
04 Feb 2025Purchase
04 Feb 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.